Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Ablâpositive cells
Thiesing, J. Tyler, Ohno-Jones, Sayuri, Kolibaba, Kathryn S., Druker, Brian J.Volume:
96
Journal:
Blood
DOI:
10.1182/blood.v96.9.3195
Date:
November, 2000
File:
PDF, 148 KB
2000